The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Sergeev A.V.

Chair of biophysical methods in medicine, Faculty of continuing medical education of the Russian University of Peoples’ Friendship;
G.N. Speransky Children's Clinical Hospital №9

Idiopathic intracranial hypertension

Authors:

Sergeev A.V.

More about the authors

Read: 22897 times


To cite this article:

Sergeev AV. Idiopathic intracranial hypertension. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(5):93‑97. (In Russ.)
https://doi.org/10.17116/jnevro20161165193-97

Recommended articles:
Vertebroplasty for pathological vertebral fracture with osteoporosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):67-76
Features of the clinical course of multiple scle­rosis as a factor in persistent disa­bility. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):39-44
Chro­nic traumatic ence­phalopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):16-24
Bacterial vagi­nosis: modern views. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):261-268
Method of photodynamic action in surgical treatment of local limi­ted peri­tonitis in the expe­riment. Russian Journal of Operative Surgery and Clinical Anatomy. 2025;(2-2):77-86
Appe­ndicular dive­rticulum in acute appe­ndix. Russian Journal of Operative Surgery and Clinical Anatomy. 2025;(2-2):117-120
Traumatic inju­ries of the rectum and anus in childhood. Piro­gov Russian Journal of Surgery. 2025;(8):62-66
Features of pero­xide-antioxidant imba­lance in patients with rosa­cea and approaches to comprehensive therapy. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):439-444

References:

  1. Wakerley BR, Tan MH, Ting EY. Idiopathic intracranial hypertension. Cephalalgia. 2015;35(3):248-261.  doi: 10.1177/0333102414534329.
  2. Caballero B. The global epidemic of obesity: an overview. Epidemiol Rev. 2007;29(1):1-5.  doi: 10.1093/epirev/mxm012.
  3. Best JL, Silvestri G, Burton BJ, Foot B, Acheson J. The incidence of blindness due to idiopathic intracranial hypertension in the UK. Open Ophthalmol J. 2013;7:26-29.  doi: 10.2174/1874364101307010026.
  4. Corbett JJ, Savino PJ, Thompson HS, Kansu T, Schatz NJ, Orr LS, Hopson D. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol. 1982;39:461-474.  doi:10.1001/archneur.1982.00510200003001.
  5. Ball AK, Clarke CE. Idiopathic intracranial hypertension. The Lancet Neurology. 2006;5:5:433-442.  doi: 10.1016/S1474-4422(06)70442-2.
  6. Szewka AJ, Bruce BB, Newman NJ, Nancy JMD, Biousse V. Idiopathic intracranial hypertension: Relation between obesity and visual outcomes. J Neuroophthalmol. 2013;33:4-8.  doi: 10.1097/WNO.0b013e31823f852d.
  7. Radhakrishnan K, Ahlskog JE, Cross SA, Kurland LT, O’Fallon WM. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol. 1993;50(1):78-80.  doi: 10.1001/archneur.1993.00540010072020.
  8. Raoof N, Sharrack B, Pepper IM, Hickman SJ. The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK. Eur J Neurol. 2011;18:10:1266-1268. doi: 10.1111/j.1468-1331.2011.03372.x.
  9. Hamdallah IN, Shamseddeen HN, Getty JLZ, Smith W, Ali MR. Greater than expected prevalence of pseudotumor cerebri: A prospective study. Surg Obes Relat Dis. 2013;9:1:77-82.  doi: 10.1016/j.soard.2011.11.017.
  10. Sinclair AJ, Burdon MA, Nightingale PG, Ball AK, Good P, Matthews TD, Jacks A, Lawden M, Clarke CE, Stewart PM, Walker EA, Tomlinson JW, Rauz S. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: Prospective cohort study. BMJ. 2010;341:2701. doi: 10.1136/bmj.c2701.
  11. Friedman DI, Jacobson D.M. Idiopathic intracranial hypertension. J Neuroophthalmol. 2004;24:138-145.  doi: 10.1097/00041327-200406000-00009.
  12. Giuseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): A case-control study. Neurology. 1991;41:2:1:239-244.  doi: 10.1212/WNL.41.2_Part_1.239.
  13. Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain. 1991;114:155-180.
  14. Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81:13:1159-1165. doi: 10.1212/WNL.0b013e3182a55f17.
  15. Kupersmith MJ, Gamell L, Turbin R, Peck V, Spiegel P, Wall M. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology. 1998;50:4:1094-1098. doi: 10.1212/WNL.50.4.1094.
  16. Fridley J, Foroozan R, Sherman V, Brandt ML, Yoshor D. Bariatric surgery for the treatment of idiopathic intracranial hypertension. J of Neurosurg. 2011;114:1:34-39.  doi: 10.3171/2009.12.JNS09953.
  17. Rachin AP, Sergeev AV. Primenenie diakarba (acetazolamid) v nevrologicheskoj praktike. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2007;12:98-102. (In Russ.).
  18. Gücer G, Viernstein L. Long-term intracranial pressure recording in the management of pseudotumor cerebri. J Neurosurg. 1978;49:2:256-263.  doi: 10.3171/jns.1978.49.2.0256.
  19. Rodriguez de Rivera FJ, Martinez-Sanchez P, Ojeda-Ruiz de Luna J, Ara-Gutierrez FJ, Barreiro-Tella P. Benign intracranial hypertension. History, clinical features and treatment in a series of 41 patients. Rev Neurol. 2003;37(9):801-805.
  20. Errguig L, Benomar A, Aitbenhaddou E, Mouti O, Regragui W, Benaaboud B, Yahyaoui M, Chkili T. Hypertension intracrânienne bénigne: Aspects cliniques et thérapeutiques. Clinical and therapeutic aspects of benign intracranial hypertension. Rev Neurol. 2004;160(12):1187-1190. doi: 10.1016/S0035-3787(04)71164-9.
  21. NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, Kupersmith MJ. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA. 2014;311(16):1641-1651. doi:10.1001/jama.2014.3312.
  22. Puffer RC, Mustafa W, Lanzino G. Venous sinus stenting for idiopathic intracranial hypertension: A review of the literature. J Neurointerv Surg. 2013;5:483-486.  doi: 10.1136/neurintsurg-2012-010468.
  23. Ko MW, Chang SC, Ridha MA. Weight gain and recurrence in idiopathic intracranial hypertension. Neurology. 2011;76:18:1564-1567. doi: 10.1212/WNL.0b013e3182190f51.
  24. Schlosser RJ, Woodworth BA, Wilensky EM, Grady MS, Bolger WE. Spontaneous cerebrospinal fluid leaks: A variant of benign intracranial hypertension. Ann Otol Rhinol Laryngo. 2006;115:495-500.  doi: 10.1177/000348940611500703.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.